Evaluation of the efficacy and safety of cytoflavin as a neuroprotector based on a systematic review
Introduction. Currently, neurological diseases occupy one of the first places in terms of the DALY (Disability-adjusted life year) index and are the second cause of death in the world. There is a tendency towards rejuvenation and an increase in morbidity. Drug therapy aimed at neuroprotection and im...
Saved in:
| Main Authors: | E. K. Krasova, I. A. Titovich, K. O. Sidorov, S. V. Okovityi |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
2025-03-01
|
| Series: | Разработка и регистрация лекарственных средств |
| Subjects: | |
| Online Access: | https://www.pharmjournal.ru/jour/article/view/2005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meta-analytical evaluation of the clinical efficacy of a complex metabolic neuroprotector in patients with chronic cerebral ischemia
by: M. V. Zhuravleva, et al.
Published: (2022-01-01) -
Cytoflavin in Polychemotherapy of Breast Cancer
by: V. A. Kashuro, et al.
Published: (2020-05-01) -
Efficacy of Cytoflavin in Therapy of Encephalophathy in Patients with Neuroinfection
by: V. A. Isakov, et al.
Published: (2020-05-01) -
The effect of cytoflavin on functional and metabolic parameters rat liver in pancreatonecrosis
by: M. S. Sukach, et al.
Published: (2012-02-01) -
Experimental Study on Cytoflavin Pharmacological Correction of Cyclophosphamide-Induced Toxic Affections of the Liver and Kidneys
by: V. A. Kashuro, et al.
Published: (2020-05-01)